Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications.
about
Bench-to-bedside review: Rhabdomyolysis -- an overview for cliniciansNGAL-Siderocalin in kidney diseaseIron traffics in circulation bound to a siderocalin (Ngal)–catechol complexIncreased plasma catalytic iron in patients may mediate acute kidney injury and death following cardiac surgeryHepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis.Progressive histone alterations and proinflammatory gene activation: consequences of heme protein/iron-mediated proximal tubule injuryErythropoietin protects against rhabdomyolysis-induced acute kidney injury by modulating macrophage polarization.Inorganic iron effects on in vitro hypoxic proximal renal tubular cell injury.Plasma catalytic iron, AKI, and death among critically ill patientsAntioxidant U74389G improves glycerol-induced acute renal failure without affecting PPARgamma gene.Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failureCytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion Injury.Acute tubular injury causes dysregulation of cellular cholesterol transport proteins.Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells.Phospholipase A2 activity can protect renal tubules from oxygen deprivation injury.Oxygen-binding haem proteins.Growth and development alter susceptibility to acute renal injury.Perioperative management of peripheral vascular trauma.Prevention of kidney injury following rhabdomyolysis: a systematic review.Catalytic iron and acute kidney injury.Protective Role for Antioxidants in Acute Kidney DiseaseComparing the potential renal protective activity of desferrioxamine B and the novel chelator desferrioxamine B-N-(3-hydroxyadamant-1-yl)carboxamide in a cell model of myoglobinuria.Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death.A case of acute renal failure and compartment syndrome after an alcoholic binge.Proximal tubule H-ferritin mediates iron trafficking in acute kidney injury.Experimental myoglobinuric acute renal failure: the effect of vitamin C.Evolution of total antioxidant status in a model of acute renal insufficiency in rats.Macrophage extracellular trap formation promoted by platelet activation is a key mediator of rhabdomyolysis-induced acute kidney injury.
P2860
Q21092898-F240C6F1-99AC-4232-B320-5F54181DB683Q26863396-9DC2B295-24C3-45DD-B58F-729AE992771FQ27662810-C3BF2220-7738-4989-AC7F-DF7D9F46F1DFQ28817921-77136BAC-9B0E-4B21-B9EE-5D09B6349236Q30300347-A8C86652-466F-4916-9F62-3E5018D57242Q33727883-F77B3CE4-E1A1-4A87-BB1C-FE2AFEE34105Q33815845-1018112B-4E9B-497E-87D6-210A8F44CBC4Q33891627-01EE9FF1-F231-4D1F-8C0C-ECBD060FF759Q34455171-33C73842-7987-4BAE-9B94-C0EFD139A123Q34584762-0165304D-7238-4410-9BC4-0F7849F5718DQ35048079-3FB68790-3B0F-4DC2-A3D4-6BBE8AB775E7Q35778470-DAFE3617-EEB0-4D8B-A542-645D025F388BQ35791601-0838FC71-F6EF-4DD1-839D-7C09B3B9AA85Q36502835-4917CE2C-A1BE-4DB4-8582-A3ADA93CFC32Q36522735-E6199A54-362C-4D66-9621-8477DFE8182EQ36992677-9E6D08F5-0A63-4D6C-984E-4546FAE0792AQ37347589-0F0DCF30-D9BC-477E-B9AE-E43CE99D9AB7Q38006459-BF658398-8357-4F1A-96A8-85B353678095Q38074512-B6DF4165-3696-4F97-AE22-0CCABE56B384Q38801048-6482926B-F49C-493A-9513-2A0C86E84A4AQ39420751-D0B7E8C8-1C84-47E8-AB10-8401896CD96FQ39592525-B654034D-8BB8-4A6E-BDEF-BD575BBE4867Q40761816-36980D0B-94D8-4ED9-AA7E-007F1115D968Q41779736-3C458500-51A0-40DA-8480-68B5536DDB7BQ41815546-104CBC61-37AB-44B8-9D65-DD56A3412B55Q42001267-0353CEAD-F7E8-4892-ADA7-FB8007B6CB62Q44544691-E4322C6E-4BA3-4FAF-B115-80B61485A2CFQ47225242-755846D6-FA49-4419-AE7D-AF62681955F3
P2860
Combined mannitol and deferoxamine therapy for myohemoglobinuric renal injury and oxidant tubular stress. Mechanistic and therapeutic implications.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Combined mannitol and deferoxa ...... and therapeutic implications.
@ast
Combined mannitol and deferoxa ...... and therapeutic implications.
@en
type
label
Combined mannitol and deferoxa ...... and therapeutic implications.
@ast
Combined mannitol and deferoxa ...... and therapeutic implications.
@en
prefLabel
Combined mannitol and deferoxa ...... and therapeutic implications.
@ast
Combined mannitol and deferoxa ...... and therapeutic implications.
@en
P2860
P356
P1476
Combined mannitol and deferoxa ...... and therapeutic implications.
@en
P2093
P2860
P304
P356
10.1172/JCI115942
P407
P577
1992-09-01T00:00:00Z